Saudi Food and Drug Authority (SFDA) requires a complete technical file for the medical device consisting mainly of the product's detailed description, design & manufacturing process, verification & validation of essential principles of safety and performance, risk management, quality management system, and post-market surveillance.
Overseas manufacturers are required to appoint an Authorized Representative (AR) to be able to apply for their medical device registration.
Local manufacturers are required to obtain a medical device manufacturing license from the Saudi FDA to apply for registration.
The registration license Medical Device Marketing Authorization (MDMA) is valid for 3 years and it can be renewed every three years.
You can initiate the renewal process with the Saudi FDA 90 days before the expiry date of the license.
There is no limit to the number of distributors that can market the product after obtaining the MDMA license.
Saudi FDA has identified 22 rules for Medical Devices and 7 rules for Invitro Diagnostic devices (IVDs) in MDS-G008 to determine the risk class of the products.
It is mainly depending on the duration of use and how far the product is invasive to the human body.
The Saudi FDA registration fee is based on the risk classification of the product as illustrated in the below table.
The legal manufacturer has the right to change the AR or appoint a new AR. This will have no impact on the registered products as long as there is no ongoing registration.
Yes. However, not for the same product.
No, this registration route was closed by the Saudi FDA on the 27th of September 2022.
Any Saudi FDA-licensed distributor can market the device in the Saudi market.
Distributors within categories C and D have the option to either obtain the ISO 13485 certificate or get audited by the Saudi FDA on an annual basis to ensure full compliance with ISO 13485 requirements.
No. However, they can be provided as supportive evidence during the registration process.
Yes, local distributors within categories A and B are mandated to obtain an ISO 13485 certificate from an SFDA or IAF-accredited certification body.
Every MDMA application can have no more than 50 trade names registered with the condition that it shall comply with the SFDA bundling criteria according to Annex (15) of MDS-REQ01.